GE HealthCare Stock Likely to Rise After FDA Approval of Flyrcado
GE HealthCare Technologies, Inc. GEHC announced that it has received FDA approval for Flyrcado (flurpiridaz F 18), a breakthrough positron...
FDA
GE Healthcare gets FDA nod for new PET imaging agent
Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief:...
GE HealthCare announces FDA approval of Flyrcado (flurpiridaz F 18) injection PET radiotracer for enhanced diagnosis of coronary artery disease
GE HealthCare’s FDA-approved flurpiridaz F 18 PET radiotracer, Flyrcado, delivers higher diagnostic efficacy in patients with known or suspected coronary...
FDA approves GE HealthCare’s flurpiridaz F-18 PET radiotracer for CAD
The U.S. Food and Drug Administration (FDA) has granted a long-awaited approval to flurpiridaz F-18, GE HealthCare's first-of-its-kind positron emission...
GE Healthcare wins FDA clearance for Alzheimer’s imaging software
Dive Brief: GE Healthcare has received 510(k) clearance for a tool designed to help clinicians assess people who may have...
